Treatment of Hodgkin’s lymphoma in childhood and adolescence without radiotherapy

We appreciate the well balanced commentaries on the final results of the GPOH-HD95 trial (1) and thank the experts for their positive and encouraging judgment as well as for important critical comments and ideas regarding the further improvement of treatment in Hodgkin lymphoma (HL) of childhood and adolescence (2-4). We also thank the editor of the Journal for giving us the opportunity to respond to these constructive statements.